中国药品流通绩效的实证研究——基于384家药品流通企业的样本数据

发布时间：2018-02-27 07:21

本文关键词： SCP范式药品流通绩效纵向竞争性横向竞争性　出处：《经济与管理》2017年01期 　论文类型：期刊论文

【摘要】：降低药品流通成本、提高药品流通绩效是当前新医改和医药产业发展的关键所在。依托SCP范式理论和384家药品流通企业的数据对药品流通市场运营绩效进行实证分析,研究发现:流通纵向竞争关系中的多环节、长渠道制约着流通绩效的提升;流通横向竞争关系中各个流通环节缺乏竞争性导致了流通的低绩效;企业的信息化水平和内部激励机制与流通绩效呈显著正相关。据此,在新一轮医改中应该提升药品流通产业集中度,加速行业整合,压缩流通环节。同时积极推进"医药分离",增强流通环节的竞争性,在药品价格形成中凸显市场机制的调节作用,规范和完善招标采购制度来减少流通环节。也应注重企业的信息化建设和激励机制的完善等以提升药品流通绩效。
[Abstract]:Reducing the cost of drug circulation and improving the performance of drug circulation are the key to the development of the new medical reform and pharmaceutical industry. Based on the SCP paradigm theory and 384 drug circulation enterprises' data, the paper makes an empirical analysis on the operational performance of the drug circulation market. It is found that the long channel restricts the promotion of circulation performance, and the lack of competition in each circulation link leads to the low performance of circulation. The informatization level and internal incentive mechanism of enterprises are significantly positively correlated with circulation performance. Therefore, in the new round of medical reform, the concentration degree of pharmaceutical circulation industry should be improved, and the integration of the industry should be accelerated. At the same time, we should actively promote the "separation of medicines", enhance the competitiveness of the circulation links, and highlight the regulatory role of the market mechanism in the formation of drug prices. In order to improve the performance of drug circulation, we should standardize and perfect the bidding and purchasing system to reduce the circulation links, and should also pay attention to the information construction of enterprises and the improvement of incentive mechanism.
【作者单位】：国家行政学院经济学教研部;河北地质大学法政学院;
【基金】：国家社科重大项目(15ZDC009)
【分类号】：F721

【相似文献】